Bellevue Life Sciences Ac...

NASDAQ: BLAC · Real-Time Price · USD
3.01
-3.72 (-55.27%)
At close: Feb 14, 2025, 3:53 PM

Bellevue Life Sciences Acquisition Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Revenue
n/a n/a n/a n/a
Cost of Revenue
n/a n/a n/a n/a
Gross Profit
n/a n/a n/a n/a
Operating Income
-3.52M -1.83M -35.39K -3.31K
Interest Income
2.18K n/a n/a n/a
Pretax Income
-2.12M 944.59K -35.39K -3.31K
Net Income
-2.41M 403.78K -35.39K -3.31K
Selling & General & Admin
3.52M 1.83M 35.39K 3.31K
Research & Development
n/a n/a n/a n/a
Other Expenses
n/a n/a n/a n/a
Operating Expenses
3.52M 1.83M 35.39K 3.31K
Interest Expense
-43.01K n/a n/a n/a
Selling & Marketing Expenses
n/a n/a n/a n/a
Cost & Expenses
n/a 1.83M 35.39K 3.31K
Income Tax Expense
-296K 540.81K n/a n/a
Shares Outstanding (Basic)
4.48M 7.69M 9.05M 7.93M
Shares Outstanding (Diluted)
4.48M 7.72M 9.05M 7.93M
EPS (Basic)
-0.54 0.07 -0.00 -0.00
EPS (Diluted)
-0.54 0.07 -0.00 -0.00
EBITDA
-3.52M 944.59K -35.39K -3.31K
EBIT
n/a 944.59K -35.39K -3.31K
Depreciation & Amortization
n/a 2.77M 228.49K 236.56K